Active

Bex Pharma

Switched

BE0681988489

Rechtspersoon Private limited company 1 establishment

Broekstraat 28, 9255 Buggenhout Activiteiten van holdings

Active for

8 year, 11 months

Financials

Financial year 2025

Gross margin

€ 84,938

▼ 18% vs 2024

Profit

Healthy

€ 30,226

▼ 63% vs 2024

Debts

Normal

€ 816,976

▼ 10% vs 2024

Bex Pharma from Buggenhout, company number BE0681988489, closed financial year 2025 with a result of € 30,226 after tax. For that financial year Bex Pharma recorded a gross margin of € 84,938 and equity of € 319,718. Compared with financial year 2024, the result moved from € 81,439 to € 30,226. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on March 31, 2026.

What happened at Bex Pharma?

What happened at Bex Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 30,226 (▼ 63% vs 2024). Source: NBB ↗
  • New establishment in Buggenhout. KBO
  • Start of the company according to the CBE. KBO
  • Liesbet Heyvaert became a director. NBB

In short

From € 62,740 profit in 2021 to € 30,226 profit in 2025.

Paid € 120,032 in corporate taxes since 2021.

Best year ever: 2022, with € 127,249 profit.

Paid out € 168,359 in dividends to the owners in total.

A new publication or filing at Bex Pharma? We notify you, reason included.

Follow Bex Pharma

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Liesbet Heyvaert
Bex Pharma

Behind Bex Pharma is Liesbet Heyvaert. It owns 45% of Opniphar itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Liesbet Heyvaert

Bestuurder

Also active at: OPNIPHAR

since 2017

Establishments

Establishment units

Physical locations of this company

Registered office

Broekstraat 28

9255 Buggenhout

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

Details

Company number
0681.988.489
VAT number
BE 0681.988.489
Registered office
Broekstraat 28, 9255 Buggenhout
Names & denominations
Bex Pharma
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
2 October 2017
Peppol
Active · Active since 24 Nov 2023
Activities · NACE

Activiteiten van holdings

Holdings

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Frequently asked questions

What is the enterprise number of Bex Pharma?
The enterprise number of Bex Pharma is BE0681988489.
What is the address of Bex Pharma?
The registered office of Bex Pharma is located at Broekstraat 28, 9255 Buggenhout.
When was Bex Pharma founded?
Bex Pharma was founded on 2 October 2017.
What is the main activity of Bex Pharma?
The main activity of Bex Pharma is "Activiteiten van holdings" (NACE code 64210).
Does Bex Pharma have a website?
No website is currently known for Bex Pharma.
How much profit did Bex Pharma make in 2025?
Bex Pharma posted a profit after taxes of € 30,226 in financial year 2025.
What is the revenue of Bex Pharma?
As a small company, Bex Pharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 84,938.
Where can I find the annual accounts of Bex Pharma?
Bex Pharma files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Bex Pharma?
According to the 2025 annual accounts, the directors of Bex Pharma are: Liesbet Heyvaert.
Who owns Bex Pharma?
Behind Bex Pharma is Liesbet Heyvaert. It owns 45% of Opniphar itself.